Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.
Josefina Gutiérrez MartínezHugo SandovalIván Pérez-NeriAntonio ArauzJuan Carlos López-HernándezCarlos Javier Pineda-VillaseñorPublished in: Rheumatology international (2021)
Peripheral neuropathy in patients with rheumatoid arthritis is associated with a maladaptive autoimmune response that may cause chronic pain and disability. Nerve conduction studies are the routine method performed when rheumatologists presume its presence. However, this approach is invasive, may not reveal subtle malfunctions in the early stages of the disease, and does not expose abnormalities in structures surrounding the nerves and muscles, limiting the possibility of a timely diagnosis. This work aims to present a narrative review of new technologies for the clinical assessment of peripheral neuropathy in Rheumatoid Arthritis. Through a bibliographic search carried out in five repositories, from 1990 to 2020, we identified three technologies that could detect peripheral nerve lesions and perform quantitative evaluations: (1) magnetic resonance neurography, (2) functional magnetic resonance imaging, and (3) high-resolution ultrasonography of peripheral nerves. We found these tools can overcome the main constraints imposed by the previous electrophysiologic methods, enabling early diagnosis.
Keyphrases
- high resolution
- peripheral nerve
- rheumatoid arthritis
- chronic pain
- magnetic resonance imaging
- magnetic resonance
- contrast enhanced
- multiple sclerosis
- disease activity
- mass spectrometry
- ankylosing spondylitis
- interstitial lung disease
- pain management
- chemotherapy induced
- systemic lupus erythematosus
- dna methylation
- genome wide
- systemic sclerosis
- diffusion weighted imaging
- drug induced
- fluorescence imaging